Drug Prices and Coverage

Summary

The bill requires pharmacy benefit managers to provide a clear administrative appeal process for pharmacies that dispute reimbursement rates, prohibits PBMs from forcing pharmacies to dispense drugs at a loss or from unequal reimbursement, and allocates $30.9 million to the Ryan White Part B AIDS Drug Assistance Program for low‑income patients through June 2026. It affects PBMs, pharmacies, and low‑income individuals living with HIV/AIDS, aiming to improve drug pricing transparency and access.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share